Abstract No. 484 Transcatheter arterial embolization for adhesive capsulitis: a systematic review

To systematically review published literature on transcatheter arterial embolization (TAE) for abnormal neovessels in patients with adhesive capsulitis A systematic was performed using three databases following Preferred Reporting Items Systematic Reviews and Meta-analyses (PRISMA) guidelines. Outcome measures collected include Analog Scale (VAS) Score, the American Shoulder Elbow Surgeons Score (ASES), improvement anterior elevation, external rotation complications. Two prospective studies one retrospective chart were included analysis. total of 30 enrolled over studies, a mean age 53.55 years an average pain duration 10.43 months. Before embolization, 32 (80%) underwent conservative management corticosteroid injections, 24 (60%) nonsteroidal anti-inflammatory drugs, 23 (57.5%) physical therapy, 7 (17.5%) tramadol, 3 (7.5%) extracorporeal shockwave therapy. Imipenem/ cilastatin sodium suspension used 39 (97.5%) Embosphere (Merit Medical, Utah) 1 (2.5%) patient 3.54 mL embolic agent each case thoracoacromial being most commonly targeted artery (60%). Technical success 100%, neovascularity reported all treated shoulders. Average VAS score improved from baseline at week, month, months, 6 months (77.25 vs. 56.12, 46.75, 17.90, 8.43, respectively). Nighttime scores (67.78 36.37, 26.31, 9.03, 2.78). Mean range motion elevation increased year (74.37 74, 90.40, 121.40, 150 165), increase (8. 21 11, 16.09, 36.18. 51.96, 58) ASES during same time (16.47 24.5, 41.07, 68.02, 81.92, 90.6). Minor adverse events such as sensation procedure (5/40, 12.5%), radial spasm (2/40, 5%), puncture site (1/40, 2.5%), fever 2.5%) reported. Limited observational report TAE to be clinically promising treatment related pain. Future should standardized facilitate comparison consistent outcome variables sham intervention.